This technology is a polyclonal antibody developed through rabbit immunization using a bacterially expressed recombinant fragment of human FKBP38 (amino acids 1–207). It is designed to specifically detect endogenous FKBP38 in both human and mouse cells and has been rigorously validated through western blotting and immunofluorescence assays. The antibody targets a critical region of FKBP38, which is implicated in mTOR signaling and mitochondrial regulation, and has been successfully applied in diverse experimental settings. It has demonstrated high specificity and affinity, ensuring minimal non-specific interactions during detection, and has been effectively incorporated into multiple research projects investigating cellular regulation and cancer biology.